Epoetin Alfa Improves Anemia and Anemia-Related, Patient-Reported Outcomes in Patients with Breast Cancer Receiving Myelotoxic Chemotherapy: Results of a European, Multicenter, Randomized, Controlled Trial

PURPOSE. To evaluate the effects of epoetin alfa on patient-reported outcomes (PROs) in patients with breast cancer receiving myelotoxic chemotherapy. MATERIALS AND METHODS. Women with hemoglobin concentrations ≤12.0 g/dl and an Eastern Cooperative Oncology Group performance status (ECOG PS) score o...

Descripción completa

Detalles Bibliográficos
Autores principales: Pronzato, Paolo, Cortesi, Enrico, van der Rijt, Carin C., Bols, Alain, Moreno-Nogueira, José A., de Oliveira, Carlos Freire, Barrett-Lee, Peter, Ostler, Peter J., Rosso, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2010
Materias:
Academia–Pharma Intersect
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228044/
https://www.ncbi.nlm.nih.gov/pubmed/20798194
http://dx.doi.org/10.1634/theoncologist.2009-0279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228044/
https://www.ncbi.nlm.nih.gov/pubmed/20798194
http://dx.doi.org/10.1634/theoncologist.2009-0279

Ejemplares similares